A variety of studies have been performed to investigate the clinical relevance of PON-1 in cardiovascular disease, diabetes, cancer, or neurologic diseases; however, the received data are still insufficient and, in some cases, contradictory [63]. This evidence concerns the gene PON1 and diabetes mellitus.